Private Equity Deal-making Surges, with Gains in the Middle Market

After a quiet period set off by the coronavirus pandemic, private equity deal activity in the United States surged through mid-November. (authored by RSM US LLP)

2020-12-17T13:16:33-05:00December 16, 2020|Categories: Transaction Advisory|Tags: , |

M&A Due Diligence in the Era of Covid-19: PPP Loans Considerations

The Covid-19 pandemic has disrupted most economic sectors worldwide prompting governments to enact emergency stimulus measures to help businesses navigate the situation.

2020-12-08T18:05:35-05:00December 9, 2020|Categories: PBMares COVID-19 Insights, Transaction Advisory|Tags: , |

It’s Déjà Vu All Over Again for Physician Practice Acquisitions

What goes around comes around. In a trend mirroring that which occurred in the 1990s, physician practices are selling out to hospitals and private equity firms in increasing numbers.

2020-12-08T15:19:23-05:00September 24, 2020|Categories: Healthcare, Transaction Advisory|Tags: , |

Keys to Addressing the EBITDA Impact of COVID-19

(authored by RSM US LLP) COVID-19 has significantly reduced M&A activity during the first and second quarters of 2020 and it is unclear when deal activity will get back to pre-pandemic rates.

2020-07-16T17:49:59-04:00July 16, 2020|Categories: Business Advisory, Consulting, Transaction Advisory|

Due Diligence Should Be More Than Numbers

Whether it is to gain access to new technologies or increase resources and market presence, more companies, large and small are considering a merger or acquisition. 

Go to Top